Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience

Autor: François Lucia, Carole Mievis, Nicolas Jansen, Bernard Duysinx, François Cousin, Thomas Louis, Manon Baiwir, Christelle Ernst, Michel Wonner, Roland Hustinx, Pierre Lovinfosse, Philippe Coucke
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100720- (2024)
Druh dokumentu: article
ISSN: 2405-6308
DOI: 10.1016/j.ctro.2023.100720
Popis: Purpose: To evaluate the impact of dosimetric parameters on efficacy of stereotactic body radiation therapy (SBRT) in early-stage non-small cell lung cancer (ES-NSCLC), using Hypofractionated Treatment Effects in the Clinic (HyTEC) reporting standards. Methods: From April 2010 to December 2020, 497 patients who received SBRT for ES-NSCLC at the University Hospital of Liège were retrospectively enrolled. A total dose of 40 to 60 Gy in 3–5 fractions (72–180 Gy biologically effective dose with an α/β ratio of 10 (BED10)) was prescribed to the 80 % isodose line of the PTV. Potential clinical and dosimetric predictors of recurrence, overall survival (OS) and disease specific survival (DSS) were evaluated using univariate and multivariate analyses. Results: After a median follow-up of 32 months (range 3–143 months), the local control and disease-free survival (DFS) rates at 3 years were 91 % (95 % CI: 90 %–93 %) and 75 % (95 % CI: 73 %–77 %), respectively. The median OS was 41.6 months and the median DSS was not reached. On multivariate analysis, a higher gross tumor volume (GTV) Dmax (BED10) (cut-off 198 Gy) and a larger percent of the GTV receiving ≥110 % of the prescribed dose were predictive of a better local control, only GTV volume was correlated with DSS and no parameter was correlated with OS and regional or distant recurrences. Conclusion: Lung SBRT for ES-NSCLC in 3 to 5 fractions resulted in high local control rates. A higher percent of GTV receiving ≥110 % of the prescribed dose and a higher GTV Dmax (BED10) seem to allow a better local control.
Databáze: Directory of Open Access Journals